End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,349 MXN | +1.45% | -.--% | +8.63% |
06-05 | DuPont Appoints James A. Lico to Board of Directors | CI |
06-04 | Dupont De Nemours Insider Sold Shares Worth $405,775, According to a Recent SEC Filing | MT |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company's profit outlook over the next few years is a strong asset.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Sales forecast by analysts have been recently revised upwards.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- With an expected P/E ratio at 30.59 and 22.5 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- With an enterprise value anticipated at 3.17 times the sales for the current fiscal year, the company turns out to be overvalued.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Diversified Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+8.63% | 33.55B | - | ||
+2.96% | 77.48B | B | ||
+14.34% | 18.82B | B | ||
+12.46% | 11.88B | A- | ||
-3.18% | 10.45B | - | ||
-22.18% | 10.17B | B | ||
-1.06% | 9.03B | A- | ||
-7.41% | 8.15B | C- | ||
-4.14% | 7.54B | B | ||
-13.07% | 5.72B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- DD Stock
- DD * Stock
- Ratings DuPont de Nemours, Inc.